Pharmaceutical giant Roche inaugurated Switzerland’s tallest building on Friday. The 205-metre-tall structure in Basel, known as Building 2, will house 3,500 workers.
The new high rise surpasses the firm’s nearby tower – Building 1 – which stands at 178 metres.
The new 50-floor high-rise office, with a total floor space of 83,000 metres, was designed by the renowned Swiss architectural firm Herzog & de Meuron; it cost CHF550 million ($561 million) to build.
The white, sleek staircase shaped towers can be seen from nearly everywhere in Basel in northwest Switzerland.
“Building 2 is another highly visible sign of Roche’s commitment to Basel – the city where Roche was founded over 125 years ago,” said Roche CEO Severin Schwan in a statementExternal link on Friday.
Tight planning regulation restrictions in many Swiss urban areas mean that there are few skyscrapers in Switzerland.
The construction of the twin towers in Basel allows Roche to bring together staff who were previously working in different locations across the city. Two thousand employees work in Building 1.
The pharma giant is continuing its investment in Basel with plans for a new CHF1.2 billion research & development centre, which is due to open in autumn 2024.
Roche is one of the biggest private employers in Switzerland with 15,000 staff based on four sites (two in Basel, and others in Zurich and Rotkreuz); it employs 100,000 people worldwide.
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Swiss-backed ‘Hera’ asteroid mission hits key milestone with Mars flyby
This content was published on
According to the European Space Agency (ESA), the Red Planet’s gravity will tweak the probe’s path, cutting months off the journey and saving a lot of fuel.
Swiss man arrested over Geneva parcel bomb attacks
This content was published on
A 61-year-old Swiss man was arrested in Geneva in connection with the parcel bomb incidents that left a man and a 12-year-old girl seriously injured.
UN officials in Geneva report over 100 civilian executions in western Syria
This content was published on
Verification is ongoing, and the actual number is likely higher, said a UN spokesperson in Geneva. A Syrian NGO claims executions could exceed 1,000.
Swiss pharma giant Roche partners with Zealand Pharma on new obesity treatment
This content was published on
Roche announced that it has struck an exclusive deal with Denmark's Zealand Pharma to develop and market petrelintide, a new treatment for obesity.
Experts lower Swiss growth forecasts due to US trade tensions
This content was published on
The uncertainty caused by ongoing trade conflicts is making companies hesitant to make decisions, which significantly hinders investment.
Swiss abbot resumes role following abuse investigation
This content was published on
Scarcella was accused in the Catholic Church abuse scandal last autumn. In October 2024, the Vatican declared there was no evidence of abuse or harassment against him.
Swiss stock exchange operator SIX to cut 150 jobs in efficiency drive
This content was published on
"We're not revealing the number of job losses at each location at the moment," said a SIX spokesperson. However, there will be cuts in Switzerland as well.
Martin Pfister named new Swiss government minister
This content was published on
Pfister’s election keeps the linguistic balance of Switzerland’s government, but shifts gender balance to only two women.
Swiss interior minister meets UN leaders in New York for women’s rights session
This content was published on
The Swiss interior minister also held bilateral meetings with UN Secretary-General António Guterres and Sima Sami Bahous, Executive Director of UN Women
The image of foreigners in Switzerland has deteriorated
This content was published on
The Federal Statistical Office has found that Swiss people’s views of foreigners have worsened over the last couple of years.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
What’s behind the Novartis job cuts?
This content was published on
The recent decision by the Swiss drugmaker to shed 7% of its workforce is more than just a cost-cutting measure - it’s a turning point for Novartis.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.